Current insulin infusion set failure criteria may be too stringent for real-life settings and may skew infusion set failure outcomes in extended-wear infusion set studies

Diabetes Obes Metab. 2023 Apr;25(4):1106-1111. doi: 10.1111/dom.14935. Epub 2022 Dec 23.

Authors

Jasmin R Kastner¹, Tina Poettler², Julia Kopanz², Daniel A Hochfellner², Matt Romey¹, Petra M Baumann², Douglas Muchmore¹, Paul J Strasma¹, Julia K Mader²

Affiliations

¹ Capillary Biomedical Inc, Irvine, California, USA.
² Medical University of Graz, Division of Endocrinology and Diabetology, Graz, Austria.

PMID: 36482830
DOI: 10.1111/dom.14935

No abstract available

Keywords: CSII; extended-wear insulin infusion sets; insulin infusion set failure criteria; insulin pumps.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Diabetes Mellitus, Type 1* / drug therapy
Humans
Hypoglycemic Agents / therapeutic use
Insulin Infusion Systems
Insulin* / therapeutic use

Substances

Insulin
Hypoglycemic Agents